News
Increased Health Risks Associated with Meridia (Sibutramine Hydrochloride)
January 25, 2010
The FDA has notified health care professionals to stop prescribing sibutramine to patients with cardiovascular disease including:
- A history of coronary artery disease (e.g., heart attack, angina)
- A history of stroke or transient ischemic attack (TIA)
- A history of heart arrhythmias
- A history of congestive heart failure
- A history of peripheral arterial disease
- Uncontrolled hypertension (e.g., > 145/90 mmHg)
These patients face an increased risk of heart attack and stroke.
Patients currently using sibutramine should talk with their physician to determine if continued use of this product is appropriate for them.
Please read the complete MedWatch 2010 Safety Summary for more information.
Quick Links
Drug Recalls
Prescription
- LifeScan Recalls OneTouch® SureStep® Test Strips
- Important Boxed Warning Change for Exjade (Deferasirox)
- View archives
Over-the-Counter